ARIAD Pharma (ARIA) to Cut HQ Workforce by ~25%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
ARIAD Announces Reduction in Workforce as Part of Ongoing Company-Wide Strategic Review
March 29, 2016 12:51 PM EDTApproximately 25 Percent of its Headquarter Positions to be Impacted
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it is reducing approximately 25 percent of its headquarter positions. The reduction includes approximately 90 positions in the U.S. and Europe. No customer-facing positions within ARIADs commercial or medical affairs organizations are included in this action.
This reduction in workforce is one of five key areas of ARIADs ongoing strategic review. In addition to the decision announced today, the review also includes an evaluation of commercial maximization... More
